Monitoring bei Präeklampsie und kardiovaskulären Erkrankungen in der Schwangerschaft
Tóm tắt
Tài liệu tham khảo
European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), Regitz-Zagrosek V et al (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32(24):3147–3197. https://doi.org/10.1093/eurheartj/ehr218
Roche Diagnostics (Schweiz) AG (2018) Praeklampsie. Neue Marker zur Diagnoseunterstutzung und Vorhersage: Elecsys® PlGF und sFlt-1. http://www.roche-diagnostics.ch/content/dam/corporate/roche-dia_ch/documents/broschueren/professional_diagnostics/serumarbeitsplatz/immunologie/schwangerschaft/07396104001_DE_Preeklampsie.pdf. Zugegriffen: 7. Aug. 2018
pregnancy ATFoHi. HypertensioninPregnancy. In; 2013
Goland S, Elkayam U (2018) Peripartum cardiomyopathy: approach to management. Curr Opin Cardiol 33:347–353
Bello N, Rendon ISH, Arany Z (2013) The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol 62:1715–1723
Mebazaa A, Yilmaz MB, Levy P et al (2015) Recommendations on pre-hospital & early hospital management of acute heart failure. Eur J Heart Fail 17:544–558 (a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine)